Yasumasa Goh

Title: Yasumasa Goh and Ophthalmic Prostaglandin Inventions.

Introduction

Yasumasa Goh is an inventor associated with Sanda, Japan, and Shionogi Company Limited. His listed patent work concerns 15-deoxyprostaglandin derivatives and their potential use in reducing intraocular pressure and treating glaucoma.

Latest Patents

The supplied information lists two patents titled “Treatment for hypertension or glaucoma in eyes.” One describes 15-deoxyprostaglandin derivatives, including specified chemical structures and pharmaceutically acceptable salts, as active ingredients in pharmaceutical formulations intended to reduce intraocular pressure. The other describes applying a therapeutic amount of such a derivative to the eye and includes a kit for delivering a topical solution in a controlled dosage.

Goh is credited with 2 patents in the information provided. The patent descriptions focus on potential ophthalmic treatments, particularly topical approaches to managing elevated eye pressure and glaucoma.

Career Highlights

Goh’s listed inventions connect medicinal chemistry with ophthalmic drug delivery. His work at Shionogi Company Limited is associated with research into prostaglandin-based compounds and their possible therapeutic applications.

Collaborations

The supplied information names Morio Kishi and Kenji Kawada as Goh’s coworkers. It does not specify their roles in the listed patent work.

Conclusion

Yasumasa Goh’s listed patent contributions center on 15-deoxyprostaglandin derivatives and topical treatments intended to reduce intraocular pressure, reflecting an intersection of pharmaceutical invention and eye care.